HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis.
about
Hepatitis C virus non-structural protein NS5A interacts with FKBP38 and inhibits apoptosis in Huh7 hepatoma cellsPhosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replicationHepatitis C Virus Infection Induces Autophagy as a Prosurvival Mechanism to Alleviate Hepatic ER-Stress ResponseDisruption of Bcl-2 and Bcl-xL by viral proteins as a possible cause of cancerClassical swine fever virus NS5A protein changed inflammatory cytokine secretion in porcine alveolar macrophages by inhibiting the NF-κB signaling pathwayHepatitis C virus NS5A-mediated activation of phosphoinositide 3-kinase results in stabilization of cellular beta-catenin and stimulation of beta-catenin-responsive transcriptionIdentification of Residues Required for RNA Replication in Domains II and III of the Hepatitis C Virus NS5A ProteinHepatitis C Virus Infection Induces Apoptosis through a Bax-Triggered, Mitochondrion-Mediated, Caspase 3-Dependent PathwayActivation of Ribosomal RNA Transcription by Hepatitis C Virus Involves Upstream Binding Factor Phosphorylation via Induction of Cyclin D1Hepatitis C virus and hepatocarcinogenesisQuantitative Proteomics Analysis of the Hepatitis C Virus Replicon High-Permissive and Low-Permissive Cell LinesHepatitis C Virus Indirectly Disrupts DNA Damage-Induced p53 Responses by Activating Protein Kinase R.Induction of p53, p21 and apoptosis by silencing the NF90/NF45 complex in human papilloma virus-transformed cervical carcinoma cells.Ribavirin resistance in hepatitis C virus replicon-containing cell lines conferred by changes in the cell line or mutations in the replicon RNA.The oncogenic role of NS5A of hepatitis C virus is mediated by up-regulation of survivin gene expression in the hepatocellular cell through p53 and NF-κB pathways.Hepatitis C virus NS5A activates the mammalian target of rapamycin (mTOR) pathway, contributing to cell survival by disrupting the interaction between FK506-binding protein 38 (FKBP38) and mTORStructural and molecular basis of interaction of HCV non-structural protein 5A with human casein kinase 1α and PKR.Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factor.Viral hepatocarcinogenesis.Hepatitis C virus NS2 protein inhibits DNA damage pathway by sequestering p53 to the cytoplasm.Viral carcinogenesis: factors inducing DNA damage and virus integrationEffect of hepatitis C infection on HIV-induced apoptosisDownregulation of Gadd45beta expression by hepatitis C virus leads to defective cell cycle arrest.TP53 and MDM2 gene polymorphisms and risk of hepatocellular carcinoma among Italian patients.Oncogenic potential of hepatitis C virus proteinsShould NS5A inhibitors serve as the scaffold for all-oral anti-HCV combination therapies?Virus-host cell interactions during hepatitis C virus RNA replication: impact of polyprotein expression on the cellular transcriptome and cell cycle association with viral RNA synthesis.Tumor suppressors, chromosomal instability, and hepatitis C virus-associated liver cancer.Hepatitis C virus infection: establishment of chronicity and liver disease progressionFUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53.Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis.Modulation of apoptosis as a target for liver disease.Hepatitis C virus and cellular stress response: implications to molecular pathogenesis of liver diseases.HCV NS5A abrogates p53 protein function by interfering with p53-DNA binding.Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategiesAnkyrin Repeat Domain 1 is Up-regulated During Hepatitis C Virus Infection and Regulates Hepatitis C Virus Entry.Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancerPhosphorylation drives an apoptotic protein to activate antiapoptotic genes: paradigm of influenza A matrix 1 protein function.How Hepatitis C Virus Leads to Hepatocellular Carcinoma: A Network-Based Study.Hepatitis C virus infection and apoptosis
P2860
Q24297145-10E47AA2-9620-40FA-BF61-73A49E2BA7A7Q24561987-75B5ED7D-3FD7-4A32-A81C-3877E7BDE09FQ26745984-58A17F75-B9DB-4ABF-BF8A-B1586C30FD28Q27020978-FF461969-6FDE-486F-B5FF-775E42093695Q27469064-64462BC7-60D5-4B94-8039-00F32C728E19Q27469443-CDB997B3-5A68-4511-92CC-5A3B9AF919A2Q27485314-63C2FE5A-574E-4089-8BC0-E2B8CBDA753AQ27487135-1FFD6285-9738-4C5B-A8B6-F39115B6363CQ27487978-1D963D1D-324F-4C4E-A4DD-A60200FB3125Q28283484-BCD99ADB-F16C-42EA-BF2A-C1B4BC849F8EQ28550751-33EDB1E0-EBFA-4FC9-8390-1F1167A7B778Q33603822-51012461-A5A6-40FF-A1AC-D208E0C9FB21Q33656171-67AD0BD9-622A-425B-A127-4FF958B594EAQ33782525-FA11A81B-47BB-4682-BDAC-74095C129F38Q33911621-C841F796-8D56-42BB-B7F9-BCED5AD705B9Q33966987-077FD822-6F91-4B95-920B-33AE89048F47Q34475801-CC3CBA72-B745-4B37-A3C4-26CACE2DB834Q34574890-80FCB440-75D2-42C4-9BEF-790DD3AA7DE3Q34617749-F46EF722-808E-40A0-9A40-87B59A194AE7Q34701793-A7E37A3F-6352-489C-8910-07D699246178Q34774880-897B4B62-C212-454C-A6A2-1068012ACC8EQ35009175-3427D4B9-569B-4CB7-88F2-FDFF2205AB46Q35075425-7981FBD7-2B34-4C68-BDC2-CEC6381CCF65Q35206102-09A6A04B-6533-4A42-861C-C09497BEEE3BQ35261292-33D5741F-22FE-4D04-94B7-630BE057457EQ35491398-D5932B3F-4B30-452E-B881-E64AA6ED951CQ35544097-507198E5-576A-45C3-B09D-C7D8E3B1894CQ35576670-4AEB65C7-2748-4E3D-B718-AF6E7675F4A1Q35728873-CE4F94A0-4A61-4C31-A106-B95EE9A553BAQ35861153-067CE8ED-9F04-48F9-A068-C41DA63CC540Q35882733-C3632003-FC0E-478C-AC5E-97612D96B708Q36066290-38E77E91-B232-4D01-BE84-1BEAE081DC1DQ36395865-9BF15860-3155-4A68-87EE-0F906323D449Q36496442-6E4F7B3A-E248-4D98-886B-D99AEEFA7FF4Q36561567-142FB259-93C7-4601-AFB9-923325B4E884Q36565565-EDD682F9-8B0A-4CEE-AC68-DDCC3C67426DQ36812745-8C15AD1F-1E6A-4332-A4F0-34BD480D3978Q36850385-8FC0219A-9943-41A7-8600-0645EB233114Q36854662-20970960-69D8-4FC8-9A09-E4E5582065B7Q36935539-1F0D9AA8-4C50-49C6-9192-8590DAF0B4B4
P2860
HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis.
@en
type
label
HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis.
@en
prefLabel
HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis.
@en
P2093
P2860
P356
P1433
P1476
HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis.
@en
P2093
Full-Young Chang
Jaw-Ching Wu
Keng-Hsin Lan
Masao Omata
Meei-Ling Sheu
Naoya Kato
Sang-Hue Yen
Shinn-Jang Hwang
Shiow-Yi Chen
Shou-Dong Lee
P2860
P2888
P304
P356
10.1038/SJ.ONC.1205589
P407
P577
2002-07-01T00:00:00Z
P5875
P6179
1035125877